Mazza T, et al
Journal of Medicinal Chemistry , 61(15), 64156425
Standard practice includes: Baseline thyroid function tests (TSH and free T4) before initiating GLP-1 therapy Repeat testing at 812 weeks after starting treatment or after dose escalation Regular monitoring every 36 months during active weight loss Return to annual monitoring once weight is stable and thyroid function remains consistent Adjustments to levothyroxine dosing may be necessary as weight changes
Let it dry for 10 seconds
Remember: every small effort you make towards educating patients about injecting semaglutide can lead to significant improvements in their overall health and well-being
And in the COM group, participants had nausea (9/17), vomiting (5/17), diarrhea (6/17), dyspepsia (2/17), anorexia (2/17), constipation (1/17), headache (1/17), hypoglycemia (1/17), and liver dysfunction (1/17)